Medications for Merkel Cell Carcinoma

3 results

  • bavencio - avelumab injection, solution, concentrate

    (Avelumab)
    Emd Serono, Inc.
    Bavencio (avelumab) is a PD-L1 blocking antibody indicated for metastatic Merkel cell carcinoma (adults and patients 12+), locally advanced or metastatic urothelial carcinoma (maintenance after platinum chemotherapy or following progression on platinum chemotherapy), and advanced renal cell carcinoma (first-line, with axitinib).
    Medication Details
    Drug Interactions

  • keytruda - pembrolizumab injection, powder, lyophilized, for solution

    (Pembrolizumab)
    Merck Sharp & Dohme Llc
    KEYTRUDA is a PD-1 blocking antibody that treats multiple cancers—including melanoma, lung, head and neck, bladder, colorectal, gastric, cervical, breast, and renal cancers—as well as MSI-H/dMMR and TMB-H solid tumors, used across neoadjuvant, adjuvant, and metastatic settings.
    Medication Details
    Drug Interactions

  • zynyz - retifanlimab - dlwr injection

    (Retifanlimab-Dlwr)
    Incyte Corporation
    ZYNYZ treats squamous cell carcinoma of the anal canal (SCAC) — with carboplatin and paclitaxel as first-line therapy, or as a single agent after platinum-based chemotherapy. Also indicated for metastatic or recurrent locally advanced Merkel cell carcinoma (MCC) in adults.
    Medication Details
    Drug Interactions